Past year: ▲ 28%(53.0c – 1.73 USD)
Each one in plain English, with the numbers worked through for a shareholder.
13 Oct 2023capital raising announcement▼ Bad
Verde Bio took a third note from 1800 Diagonal Lending LLC, $97,750 at 11% interest, maturing July 2024 - continued reliance on small convertible-note financing even as its cash-funded royalty acquisitions grew larger.
24 Jan 2023capital raising announcement▼ Bad
Verde Bio took a second note from 1800 Diagonal Lending LLC, $71,960 at 12% interest on the same default-triggered conversion terms.
21 June 2022capital raising announcement▼ BadMajor
A year after paying off its old GHS convertible notes, Verde Bio took on a new toxic-style lender: a $200,200 promissory note from 1800 Diagonal Lending LLC at 12% interest, convertible at a 75% discount to market if the company defaults.
7 June 2022capital raising announcement▼ BadMajor
Verde Bio hired New to the Street Group LLC for investor-relations and media services, paying $10,000/month plus 13 million restricted shares - a large stock issuance for a marketing contract.
1 June 2022capital raising announcement● NeutralMajor
Verde Bio sharply upsized its Series C Preferred financing facility with GHS Investments - from the roughly $1 million floated in December 2021 to up to $6 million (125 preferred shares closed initially, $125,000) - and amended its Certificate of Designation to authorize 7,600 Series C shares in total.
11 Feb 2021capital raising announcement▼ Bad
Verde Bio took another Power Up Lending Group convertible note, $43,500 on the same 12%/42%-of-market terms - filed as an identical duplicate 8-K under a separate accession number the same day, so this may represent one note counted twice rather than two.
11 Feb 2021capital raising announcement▼ Bad
Verde Bio took another Power Up Lending Group convertible note, $43,500 on the same 12%/42%-of-market terms - filed as an identical duplicate 8-K under a separate accession number the same day, so this may represent one note counted twice rather than two.
25 Jan 2021capital raising announcement▼ BadMajor
Verde Bio added a third toxic-note lender, Power Up Lending Group: a $55,500 convertible note at 12% interest, convertible after 180 days at a 42% discount to market.
6 Jan 2021capital raising announcement▼ BadMajor
Verde Bio took on a new toxic-style lender alongside GHS: a $30,556 convertible note from Quick Capital, LLC at 10% interest, convertible at a steep discount (the lesser of $0.01 or 50% of market).
17 Nov 2020capital raising announcement▼ Bad
Verde Bio took a fifth GHS Investments convertible note, $35,000 on the same 10%/60%-of-market terms, bringing this round of GHS notes to roughly $186,000 before their 2021 payoff.
28 Sept 2020capital raising announcement▼ Bad
Verde Bio took a fourth GHS Investments convertible note, $35,000 on the same 10%/60%-of-market terms.
4 June 2020capital raising announcement▼ BadMajor
Verde Bio lined up a $5 million GHS Investments equity line ahead of its oil-and-gas pivot, and separately issued 24.5 million shares to consultants and service providers - including 20 million shares to sole director and CEO Scott Cox, who approved his own grant.
30 Mar 2020capital raising announcement▼ Bad
Appiphany took a third GHS Investments convertible note, $13,000 on the same 10%/60%-of-market terms.
12 Feb 2020capital raising announcement● NeutralMajor
Appiphany formed a hemp seed and genetics joint venture with Tsilaan, LLC and Kola Venture Group, taking a 25% stake for $300,000 cash plus 1.5 million shares issued to its partners - a concrete step on the hemp pivot floated weeks earlier.
3 Feb 2020capital raising announcement▼ Bad
Appiphany took a second GHS Investments convertible note, $68,000 on the same 10%/60%-of-market terms as the note three weeks earlier.
21 Jan 2020capital raising announcement▼ BadMajor
Appiphany took on its first GHS Investments convertible note, $35,000 at 10% interest, convertible at a 60% discount to market - the start of the toxic-note debt load that would later cost $715,000 to unwind in 2021.
18 Jan 2012capital raising announcement● Neutral
Appiphany paid for services in stock rather than cash: 65,000 restricted shares to consultant Garth Roy for a two-month engagement, and a 920,000-share (~$46,000) bonus to CEO Jesse Keller.
